Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $12.3 million.

  • Relay Therapeutics' Amortizatization of Intangibles fell 65.36% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 54.55%. This contributed to the annual value of $12.3 million for FY2024, which is 14.42% up from last year.
  • Per Relay Therapeutics' latest filing, its Amortizatization of Intangibles stood at $12.3 million for FY2024, which was up 14.42% from $10.8 million recorded in FY2023.
  • Relay Therapeutics' Amortizatization of Intangibles' 5-year high stood at $12.3 million during FY2024, with a 5-year trough of -$2.1 million in FY2021.
  • For the 3-year period, Relay Therapeutics' Amortizatization of Intangibles averaged around $7.3 million, with its median value being $10.8 million (2023).
  • In the last 5 years, Relay Therapeutics' Amortizatization of Intangibles tumbled by 593.27% in 2021 and then soared by 1,010.58% in 2023.
  • Over the past 5 years, Relay Therapeutics' Amortizatization of Intangibles (Yearly) stood at $416,000 in 2020, then tumbled by 593.27% to -$2.1 million in 2021, then skyrocketed by 42.40% to -$1.2 million in 2022, then surged by 1,010.58% to $10.8 million in 2023, then climbed by 14.42% to $12.3 million in 2024.